BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 32119704)

  • 21. Transfection with Livin and Survivin shRNA inhibits the growth and proliferation of non‑small cell lung cancer cells.
    Huang Q; Zeng Y; Lin H; Zhang H; Yang D
    Mol Med Rep; 2017 Nov; 16(5):7086-7091. PubMed ID: 28901499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of livin in gastric cancer and induction of apoptosis in SGC-7901 cells by shRNA-mediated silencing of livin gene.
    Wang TS; Ding QQ; Guo RH; Shen H; Sun J; Lu KH; You SH; Ge HM; Shu YQ; Liu P
    Biomed Pharmacother; 2010 May; 64(5):333-8. PubMed ID: 19914791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antisense oligonucleotide targeting Livin induces apoptosis of human bladder cancer cell via a mechanism involving caspase 3.
    Liu C; Wu X; Luo C; Hu Z; Yin Z; He Y; Du H; Zhang W; Jiang Q; Lin Y
    J Exp Clin Cancer Res; 2010 Jun; 29(1):63. PubMed ID: 20525250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Research progress on Livin protein: an inhibitor of apoptosis.
    Yan B
    Mol Cell Biochem; 2011 Nov; 357(1-2):39-45. PubMed ID: 21617971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RPA3 is a potential marker of prognosis and radioresistance for nasopharyngeal carcinoma.
    Qu C; Zhao Y; Feng G; Chen C; Tao Y; Zhou S; Liu S; Chang H; Zeng M; Xia Y
    J Cell Mol Med; 2017 Nov; 21(11):2872-2883. PubMed ID: 28557284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of ERp29 as a biomarker for predicting nasopharyngeal carcinoma response to radiotherapy.
    Wu P; Zhang H; Qi L; Tang Q; Tang Y; Xie Z; Lv Y; Zhao S; Jiang W
    Oncol Rep; 2012 Apr; 27(4):987-94. PubMed ID: 22160175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HILPDA-mediated lipidomic remodelling promotes radiotherapy resistance in nasopharyngeal carcinoma by accelerating mitophagy.
    Zhang Y; Pang C; Zhang C; Wang Y; Wang P; Chen Y; Wang J; Hu Y; Liu C; Liang H; Xie G; Ou J
    Cell Mol Life Sci; 2023 Aug; 80(9):242. PubMed ID: 37552373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of Co-transfection with Livin and survivin shRNA expression vectors on biological behavior of HepG2 cells.
    Xu W; Chang H; Qin CK; Zhai YP
    Asian Pac J Cancer Prev; 2013; 14(9):5467-72. PubMed ID: 24175843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Berberine sensitizes nasopharyngeal carcinoma cells to radiation through inhibition of Sp1 and EMT.
    Wang J; Kang M; Wen Q; Qin YT; Wei ZX; Xiao JJ; Wang RS
    Oncol Rep; 2017 Apr; 37(4):2425-2432. PubMed ID: 28350122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Livin/BIRC7 expression as malignancy marker in adrenocortical tumors.
    Altieri B; Sbiera S; Della Casa S; Weigand I; Wild V; Steinhauer S; Fadda G; Kocot A; Bekteshi M; Mambretti EM; Rosenwald A; Pontecorvi A; Fassnacht M; Ronchi CL
    Oncotarget; 2017 Feb; 8(6):9323-9338. PubMed ID: 28030838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and role of the inhibitor of apoptosis protein livin in chemotherapy sensitivity of ovarian carcinoma.
    Liu X; Wang A; Gao H; Yuan Z; Jiao Y
    Int J Oncol; 2012 Sep; 41(3):1021-8. PubMed ID: 22766624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-125b Increases Nasopharyngeal Carcinoma Radioresistance by Targeting A20/NF-κB Signaling Pathway.
    Li LN; Xiao T; Yi HM; Zheng Z; Qu JQ; Huang W; Ye X; Yi H; Lu SS; Li XH; Xiao ZQ
    Mol Cancer Ther; 2017 Oct; 16(10):2094-2106. PubMed ID: 28698199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Livin mediates tumor cell invasion in the DU-145 cell line via NF-κB.
    Chen F; Yang D; Che X; Wang J; Li X; Zhang Z; Chen X; Song X
    Oncol Rep; 2012 Jun; 27(6):2010-6. PubMed ID: 22427141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AKR1B10 confers resistance to radiotherapy via FFA/TLR4/NF-κB axis in nasopharyngeal carcinoma.
    Liu X; Hu Z; Qu J; Li J; Gong K; Wang L; Jiang J; Li X; He R; Duan L; Luo W; Xia C; Luo D
    Int J Biol Sci; 2021; 17(3):756-767. PubMed ID: 33767586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Silencing of Livin inhibits tumorigenesis and metastasis via VEGF and MMPs pathway in lung cancer.
    Lin X; Li HR; Lin XF; Yu ME; Tu XW; Hua ZD; Lin M; Xu NL; Han LL; Chen YS
    Int J Oncol; 2015 Aug; 47(2):657-67. PubMed ID: 26094984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long noncoding RNA LINC00173 induces radioresistance in nasopharyngeal carcinoma via inhibiting CHK2/P53 pathway.
    Miao J; Chen B; Xiao Y; Huang R; Xiao X; Lu S; Zhang L; Wang X; Ouyang Y; Chen X; Chen Q; Xiang Y; Guo X; Deng X; Wang L; Mai H; Zhao C
    Cancer Gene Ther; 2023 Sep; 30(9):1249-1259. PubMed ID: 37258811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Livin may serve as a marker for prognosis of bladder cancer relapse and a target of bladder cancer treatment.
    Liu HB; Kong CZ; Zeng Y; Liu XK; Bi JB; Jiang YJ; Han S
    Urol Oncol; 2009; 27(3):277-83. PubMed ID: 18555709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-324-3p regulates nasopharyngeal carcinoma radioresistance by directly targeting WNT2B.
    Li G; Liu Y; Su Z; Ren S; Zhu G; Tian Y; Qiu Y
    Eur J Cancer; 2013 Jul; 49(11):2596-607. PubMed ID: 23583221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevation of H3K27me3 level contributes to the radioresistance of nasopharyngeal carcinoma by inhibiting OAS1 expression.
    Zhou Y; Xiao Y; Liu H; Chen Q; Zhu L; Zeng L; Liu X; Pan Y; Zhang J; Fu J; Shao C
    Am J Physiol Cell Physiol; 2024 Jan; 326(1):C60-C73. PubMed ID: 38009194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of X-linked inhibitor of apoptosis protein on survival of nasopharyngeal carcinoma patients following radiotherapy.
    Ren M; Wang Z; Gao G; Gu X; Wu L; Chen L
    Tumour Biol; 2016 Sep; 37(9):11825-11833. PubMed ID: 27048285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.